Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C548651 |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in increased expression of AKAP1 mRNA | increases expression | 19933214
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of AKAP1 mRNA | affects expression | 16483693
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of AKAP1 mRNA | decreases expression | 20018196
|
D002118 |
Calcium |
Calcium affects the expression of AKAP1 mRNA | affects expression | 15913539
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of AKAP1 mRNA | decreases expression | 20106945
|
D004041 |
Dietary Fats |
Dietary Fats results in increased expression of AKAP1 mRNA | increases expression | 18042831
|
D004958 |
Estradiol |
Estradiol affects the expression of AKAP1 mRNA | affects expression | 14699072
|
D005419 |
Flavonoids |
Flavonoids results in increased expression of AKAP1 mRNA | increases expression | 18035473
|
D005978 |
Glutathione |
Glutathione deficiency results in increased expression of AKAP1 mRNA | increases expression | 15345336
|
C041786 |
palm oil |
palm oil results in increased expression of AKAP1 mRNA | increases expression | 18042831
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of AKAP1 mRNA | increases expression | 18301758
|
D020849 |
Raloxifene |
Raloxifene affects the expression of AKAP1 mRNA | affects expression | 14699072
|
D020849 |
Raloxifene |
[Raloxifene co-treated with ESR2 protein] results in decreased expression of AKAP1 mRNA | affects cotreatment|decreases expression | 19059307
|
D013629 |
Tamoxifen |
[Tamoxifen co-treated with ESR2 protein] results in decreased expression of AKAP1 mRNA | affects cotreatment|decreases expression | 19059307
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of AKAP1 mRNA | increases expression | 19933214
|
D014501 |
Uranium |
Uranium affects the expression of AKAP1 mRNA | affects expression | 15672453
|
C005460 |
uranyl acetate |
uranyl acetate affects the expression of AKAP1 mRNA | affects expression | 15672453
|
C025643 |
vinclozolin |
vinclozolin results in decreased expression of AKAP1 mRNA | decreases expression | 18042343
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.55 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.84 | 15322242 11752688 14514962 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.55 | 18287403 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.10 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
2.09 | 11473722 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
9.87 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
9.87 | 16835633 |
MESH:D000419 |
Albuminuria |
|
Raloxifene |
4.58 | 17308373 17451421 |
MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
2.54 | 15800139 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.93 | 11748828 |
MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
3.62 | 19015723 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
3.87 | 15238619 |
MESH:D001321 |
Autistic Disorder |
|
Glutathione |
3.01 | 16917939 19267885 19056591 18929414 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
8.71 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.71 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.79 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.75 | 15746008 |
MESH:D001930 |
Brain Injuries |
|
Raloxifene |
4.46 | 16580743 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
2.32 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
2.32 | 17289903 17261762 18497071 19861407 14630087 16675129 17018787 12948864 |
MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
2.32 | 17049068 16912660 15572757 15758505 17893378 16837676 15775269 17595753 17952589 17242785 17261762 17440819 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
2.32 | 16202921 19288272 11161223 19221464 18351453 19487384 19289846 19189212 19103187 17893378 20135344 17049068 19142967 19084267 18855134 17261762 20005174 19011961 18984771 20390343 18629630 15565566 19115204 19189210 19155303 18815881 18425577 20544844 16873071 15668708 19059307 17242785 20859285 16273361 19410462 21138602 18821012 18997820 21152245 17440819 20065188 19200415 19066611 19244106 16818667 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.32 | 20435547 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.45 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.78 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.49 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
2.97 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
2.97 | 16924424 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Glutathione |
3.37 | 17015178 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
9.44 | 17572228 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
9.44 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.35 | 18850075 18670907 16120746 |
MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
3.43 | 15775269 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
11.05 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
11.05 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
11.05 | 18566989 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.14 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
7.70 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
7.70 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.09 | 16354765 15340226 12621046 8697196 15668235 |
MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
4.60 | 15800139 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.04 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.25 | 15322242 10048152 20055451 |
MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
4.32 | 14966744 |
MESH:D003550 |
Cystic Fibrosis |
|
Glutathione |
4.47 | 19747007 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.35 | 19031437 |
MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
4.14 | 17474826 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.41 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.66 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
14.92 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
14.92 | 17308373 17451421 15920148 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
14.92 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
1.53 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.74 | 11462148 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.44 | 18367378 |
MESH:D004487 |
Edema |
|
pirinixic acid |
11.32 | 12083418 |
MESH:D004487 |
Edema |
|
Raloxifene |
11.32 | 15860553 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
11.32 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.90 | 18230668 16714409 15322242 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
9.19 | 15845917 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
9.19 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
7.34 | 19148513 11473722 18566989 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
7.34 | 17893378 19155303 20544844 16202921 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.00 | 10568697 9294722 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.07 | 20426865 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.00 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
24.47 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
24.47 | 19551842 17967931 19004024 18296743 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
24.47 | 20131406 19236843 |
MESH:D005234 |
Fatty Liver |
|
Raloxifene |
24.47 | 17473493 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
24.47 | 19224547 14986274 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.22 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.44 | 11858732 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.52 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
4.17 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
14.65 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
14.65 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
14.65 | 20067830 |
MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
4.93 | 16973722 |
MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
5.30 | 16417039 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.21 | 8708960 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.59 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.32 | 10048152 11294989 |
MESH:D006331 |
Heart Diseases |
|
Raloxifene |
3.52 | 11110106 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.52 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.41 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.32 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
8.22 | 16221962 19176532 19772884 18467677 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
8.22 | 15340226 12621046 16120746 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.03 | 15709030 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.75 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.05 | 16959395 16354765 8697196 15340226 18606429 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
3.57 | 21332399 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.16 | 20558911 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
3.60 | 21332399 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
8.54 | 10903974 |
MESH:D006973 |
Hypertension |
|
Raloxifene |
8.54 | 17577099 15787275 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
8.54 | 18850075 18670907 |
MESH:D007248 |
Infertility, Male |
|
vinclozolin |
3.03 | 16467254 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
11.87 | 20412841 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
11.87 | 17296493 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
11.87 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
11.87 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
12.21 | 18457598 11836018 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
12.21 | 16393666 16627594 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
12.21 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.32 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.44 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
5.90 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
5.90 | 15618244 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
12.27 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
12.27 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
12.27 | 18625569 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Calcium |
5.05 | 16316344 |
MESH:D007889 |
Leiomyoma |
|
Raloxifene |
4.48 | 16973256 |
MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
4.72 | 16417039 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.14 | 17567588 15342952 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
2.86 | 18296743 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
4.90 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
4.90 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
4.90 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
4.90 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
7.29 | 20007298 15890375 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
7.29 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.29 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.09 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
2.24 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.24 | 19555203 11884234 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.75 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
5.92 | 11408345 11807958 16891317 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
5.92 | 19196722 16827153 14580682 19196723 11731420 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
12.65 | 19453300 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
12.65 | 19453300 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
1.88 | 19393235 12393984 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.17 | 15990972 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.79 | 16801185 |
MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
5.55 | 15863610 |
MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
3.42 | 16497877 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.49 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.13 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.00 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
8.19 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
8.19 | 16411023 |
MESH:D009232 |
Myxoma |
|
Raloxifene |
5.55 | 16343187 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
2.54 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.51 | 19410462 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
1.94 | 17405874 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
4.00 | 19200415 19196722 19189210 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.72 | 17289903 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.44 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.27 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
9.41 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
9.41 | 14600291 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
4.42 | 17217161 18674790 20518802 20132043 18457598 21332399 16723640 19632207 11836018 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
4.42 | 20558911 |
MESH:D010024 |
Osteoporosis |
|
Calcium |
7.48 | 17882678 |
MESH:D010024 |
Osteoporosis |
|
Raloxifene |
7.48 | 15775268 17882678 19059307 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
4.21 | 17893378 15579764 15758505 17823083 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
2.21 | 19401270 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.25 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.54 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.20 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
9.46 | 11222880 11118676 11399792 11896295 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
9.46 | 18220299 18042343 19015723 |
MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
4.93 | 18220299 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.87 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.60 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
2.60 | 16220300 16536755 15731164 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.60 | 15067354 |
MESH:D011472 |
Prostatitis |
|
vinclozolin |
4.93 | 18629315 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.22 | 16882103 |
MESH:D011693 |
Purpura |
|
Raloxifene |
5.55 | 15770314 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.38 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.82 | 18990726 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.03 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
4.29 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
4.03 | 19457130 |
MESH:D020521 |
Stroke |
|
Raloxifene |
3.80 | 16837676 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.90 | 12697716 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
13.71 | 19048282 |
MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
13.71 | 19048282 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
5.20 | 17572228 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
5.20 | 8653321 16712894 17572228 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.98 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.59 | 12125929 |
MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
5.21 | 16837676 |
MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
5.55 | 16343187 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.25 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.72 | 16723640 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.44 | 17120751 |